Tazarotene
- Product NDC
- 0713-0765
- 11-digit product format
- 007130765
- Labeler code
- 0713
- Product ID
- 0713-0765_3001f737-a4db-b824-e063-6294a90a784e
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Tazarotene
- Dosage form
- CREAM
- Route
- TOPICAL
- Labeler
- Cosette Pharmaceuticals, Inc.
- Application
- ANDA208662
- Marketing category
- ANDA
- Marketing start
- 2025-03-10
- Substance
- TAZAROTENE
- Active strength
- .5 mg/g
- Pharmacologic classes
- Retinoid [EPC], Retinoids [CS]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Related UNII Ingredients
| UNII | Preferred term | Registry number | Matched term |
|---|
| 81BDR9Y8PS | TAZAROTENE | 118292-40-3 | TAZAROTENE |
Packages
| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 0713-0765-31 | 00713076531 | 1 TUBE in 1 CARTON (0713-0765-31) / 30 g in 1 TUBE | 1 tube | 2025-03-10 | No | No | Historical |
| 0713-0765-60 | 00713076560 | 1 TUBE in 1 CARTON (0713-0765-60) / 60 g in 1 TUBE | 1 tube | 2025-03-10 | No | No | Historical |
Related DailyMed Labels
| Title | Manufacturer | Effective date | Type | Version |
|---|
| Tazarotene | Cosette Pharmaceuticals, Inc. | Cosette Pharmaceuticals NC Laboratories, LLC | 2025-03-10 | HUMAN PRESCRIPTION DRUG LABEL | 8 |